SynthesisEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2026
Rhinophyma: a systematic review and meta-analysis of its epidemiology, associations, and treatment outcomes.
Synthesis in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA progressive dermatologic disease often considered the advanced stage of rosacea, rhinophyma is characterized by skin thickening, sebaceous gland hyperplasia, and a bulbous nose. Mostly affecting older men, it is associated with significant cosmetic and functional problems. The current study aimed to assess the epidemiology, associations, and outcomes of management of rhinophyma. METHODOLOGY: This is a systematic review conducted based on 149 case reports, case series, and observational studies published until 2025. Patients’ demographic factors, rhinophyma severity, associated risk factors, treatment approaches, and clinical outcomes were collected. Meta-analysis was conducted to assess the satisfaction and outcomes of the treatment.
resultsThis systematic review was conducted among 2720 patients, where males presented 58.9% of the patients with a mean age of 62.9 years. Severe rhinophyma was presented in 61% of the patients, where rosacea was found in 55.8% of them. Older age and male gender were the main risk factors. The most commonly used management was surgical procedures, including the use of scalpel excision (49.0%) and CO2 laser (37.4%). Meta-analysis reported that 88% of the patients showed good satisfaction, and 94% of them reported improvement in clinical and cosmetic outcomes.
conclusionUsing surgical and laser-based treatments successfully cures rhinophyma and results in notable cosmetic and clinical benefits. Variability in therapeutic methods and negative effects, however, points to the need for established treatment plans.
Indexed as
Identifiers
41786951What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.